ClinicalTrialsFinder

High-Risk Cancer Clinical Trials

0 recruiting

Showing 1–2 of 2 trials

Recruiting
Phase 2

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more
Rana McKay, MD32 enrolled6 locationsNCT05498272
Recruiting

Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration

Lung CancerSmokingFamily Relations+2 more
Gee-Chen Chang6,618 enrolled7 locationsNCT05557487